Functional characterization of ChR variants for machine learning. In previous work, we explored structure-guided recombination 20,21 of three highly functional ChR parents (CsChrimsonR (CsChrimR) 11 , C1C2 (ref. 17 ) and CheRiff (ref. 22 )) by designing two ten-block recombination libraries with a theoretical size of ~120,000 (that is, 2 × 3 10 ) chimeric variants 9 . These recombination libraries are a rich source of functionally diverse sequences 9 . Previously, We engineered light-gated channelrhodopsins (ChRs) whose current strength and light sensitivity enable minimally invasive neuronal circuit interrogation. Current ChR tools applied to the mammalian brain require intracranial surgery for transgene delivery and implantation of fiber-optic cables to produce light-dependent activation of a small volume of tissue. To facilitate expansive optogenetics without the need for invasive implants, our engineering approach leverages the substantial literature of ChR variants to train statistical models for the design of high-performance ChRs. With Gaussian process models trained on a limited experimental set of 102 functionally characterized ChRs, we designed high-photocurrent ChRs with high light sensitivity. Three of these, ChRger1-3, enable optogenetic activation of the nervous system via systemic transgene delivery. ChRger2 enables light-induced neuronal excitation without fiber-optic implantation; that is, this opsin enables transcranial optogenetics.
C hRs are light-gated ion channels found in photosynthetic algae. Transgenic expression of ChRs in the brain enables light-dependent neuronal activation 1 . These channels are widely applied as tools in neuroscience research 2 ; however, limitations of available ChRs prohibit a number of optogenetic applications. These channels have broad activation spectra in the visible range and require high-intensity light for activation (~1 mW mm −2 ). As ChRs are naturally low-conductance channels, 10 5 -10 6 functional ChRs need to be expressed in the plasma membrane of a neuron to produce sufficient light-dependent depolarization and to induce neuronal activation 3 . In the mouse brain, ChRs require ~1-15 mW light delivered ~100 μm from the target cell population to reliably activate action potentials [4] [5] [6] . This confines light-dependent activation to a small volume of brain tissue (~1 mm 3 ) 7 . Enabling optogenetics for large brain volumes without the need to implant invasive optical fibers for light delivery would be highly desirable.
Engineering ChRs to overcome limits in conductance and light sensitivity and extend the reach of optogenetic experiments requires overcoming three major challenges. First, rhodopsins are trans-membrane proteins that are inherently difficult to engineer because the sequence and structural determinants of membrane protein expression and plasma membrane localization are highly constrained and poorly understood 8, 9 . Second, because properties of interest for neuroscience applications are assayed using lowthroughput techniques, such as patch-clamp electrophysiology, engineering by directed evolution is not feasible 10 . And third, in vivo applications require retention and optimization of multiple properties; for example, localization in mammalian cells while simultaneously tuning kinetics, photocurrents and spectral properties 6 .
Diverse ChRs have been published, including variants discovered from nature 11, 12 , variants engineered through recombination 9, 13 and mutagenesis 14, 15 , as well as variants resulting from rational design 16 . Studies of these coupled with structural information 17 and molecular dynamic simulations 18 have established some understanding of the mechanics and sequence features important for specific ChR properties 1, 16 . Despite this, it is still not possible to predict functional properties of uncharacterized ChR sequences.
Our approach has been to leverage the substantial literature of ChRs to train statistical models that enable design of highly functional ChRs. These models take as their input the sequence and structural information for a given ChR variant and then predict its functional properties. The models use training data to learn how sequence and structural elements map to ChR function. Once known, that mapping can be used to predict the behavior of untested ChR variants.
Our trained models accurately predict the properties of untested ChR sequences. We used these models to engineer 30 'designer' ChR variants with specific combinations of desired properties, a number of which have unprecedented photocurrent strength and light sensitivity. We characterized these low-light-sensitive, highphotocurrent ChRs for applications in the mammalian brain and demonstrate their potential for minimally invasive activation of populations of neurons in the brain enabled by systemic transgene delivery with the engineered adeno-associated virus (AAV), rAAV-PHP.eB (ref. 19 ). This work demonstrates how a machine learningguided approach can enable engineering of proteins that have been challenging to engineer.
we generated 102 ChR variants selected from these recombination libraries 8, 9 . Of these, 76 were previously characterized for photocurrent properties (with patch-clamp electrophysiology) and 26 we characterized here. Together, these 102 ChR recombination variants provide the primary dataset used for model training. We supplemented this dataset with data from other published sources, including 19 ChR variants from nature, 14 single-mutant ChR variants and 28 recombination variants from other libraries (Supplementary Data 1). As the data produced by other laboratories were not collected under the same experimental conditions as data collected in our hands, they cannot be used for comparison for absolute ChR properties (that is, photocurrent strength); however, these data do provide useful binary information on whether a sequence variant is functional or not. Thus, we used published data from other sources when training binary classification models for ChR function.
Because our goal was to optimize photocurrent strength, wavelength sensitivity and off-kinetics, we used these measured properties to train machine-learning models (Fig. 1a ). Enhancing ChR photocurrent strength would enable reliable neuronal activation even under low-light conditions. Different off-rates can be useful for specific applications: fast off-kinetics enable high-frequency optical stimulation 23 , slow off-kinetics are correlated with increased light sensitivity 3, 14, 15 and very slow off-kinetics can be used for constant depolarization (step-function opsins 14 ). In addition to opsin functional properties, it is also necessary to optimize or maintain plasma membrane localization, a prerequisite for ChR function 8 .
Training Gaussian process (GP) classification and regression models. Using the ChR sequence and structure as well as functional data as inputs, we trained GP classification and regression models ( Fig. 1 ). GP models successfully predicted thermostability, substrate binding affinity and kinetics for several soluble enzymes 24 , and ChR membrane localization 8 . For a detailed description of the GP model architecture used for protein engineering see refs. 8, 24 . Briefly, these models infer predictive values for uncharacterized sequences from training examples by assuming that similar inputs (ChR sequence variants) will have similar outputs (photocurrent properties). To quantify the relatedness of inputs (ChR sequence variants), we compared both sequence and structure. ChR sequence information is encoded in the amino acid sequence. For structural comparisons, we convert the three-dimensional crystal-structural information into a 'contact map' that is convenient for modeling. Two residues are considered to be in contact and potentially important for structural and functional integrity if they have any nonhydrogen atoms within 4.5 Å in the C1C2 crystal structure (3UG9.pdb) 17 . We defined the sequence and structural similarity between two variants by aligning them and counting the number of positions and contacts at which they are identical 24 .
We trained a binary classification model to predict whether a ChR sequence will be functional using all 102 training sequences from the recombination library (Supplementary Data 2) as well as data from 61 variants published by others (Supplementary Data 1). We then used this trained classification model to predict whether uncharacterized ChR sequence variants were functional ( Fig. 1b ). To test prediction accuracy, we performed 20-fold crossvalidation on the training dataset and achieved an area under the receiver operator curve of 0.78, indicating good predictive power ( Supplementary Table 1 ).
Next, we trained three regression models, one for each of the ChR photocurrent properties of interest: photocurrent strength, wavelength sensitivity of photocurrents and off-kinetics ( Fig. 1c ). Once trained, we used these models to predict photocurrent properties of untested ChRs sequence variants. To test prediction accuracy, we performed 20-fold cross-validation on the training dataset and observed high correlation between predicted and measured properties for all models (Pearson correlation coefficient (R) between 0.77 and 0.9; Supplementary Tables 1-2). Models built using contact maps from either the ChR2 crystal structure 25 or C1Chrimson crystal structure 26 perform as well as models built with a contact map from the C1C2 structure 17 (Supplementary Table 3 and Supplementary Fig. 1c,d ), even though these maps share only 82% and 89% of their contacts with the C1C2 map, respectively ( Supplementary Fig. 1a,b ).
Selection of designer ChRs using trained models. To select 'designer' ChRs (that is, ChRs predicted to have a useful combination of properties), we used a tiered approach (Fig. 1d ). First, we eliminated all ChR sequences predicted to not localize to the plasma membrane or predicted to be nonfunctional. To do this, we used classification models of ChR localization 8 and function to predict the probability of localization and function for each ChR sequence in the 120,000-variant recombination library. Not surprisingly, most ChR variants were predicted to not localize and not function. To focus on ChR variants predicted to localize and function, we set a threshold for the product of the predicted probabilities of localization and function ( Fig. 1b) ; any ChR sequence above that threshold would be considered for the next tier of the process. We selected a conservative threshold of 0.4.
The training data made clear that the higher the mutation distance from one of the three parents, the less likely it was that a sequence would be functional; however, we expect that more diverse sequences would also have the more diverse functional properties. To explore diverse sequences predicted to function, we selected 22 ChR variants that passed the 0.4 threshold and were multi-blockswap sequences containing on average 70 mutations from the closest parent. We synthesized these 22 sequences, expressed them in HEK cells and measured their photocurrent properties with patch-clamp electrophysiology. Of the tested sequences 59% were functional ( Fig. 1e ), compared with 38% of the multi-block-swap sequences randomly selected (that is, not selected by the model) and having comparable average mutation level. This validates the classification model's ability to make useful predictions about uncharacterized functional sequences, even for sequences that are very distant from those previously tested. We updated the models by including data from these 22 sequences for future rounds of predictions.
From the 120,000-variant recombination library, 1,161 chimeric sequence variants passed the 0.4 predicted localization and function threshold ( Fig. 1 ). For the second tier of the selection process, we used the three regression models trained on all functional variants collected up to this point to predict the photocurrent strength, wavelength sensitivity of photocurrents and off-kinetics for each of these 1,161 ChR sequence variants (Supplementary Data 3). We selected 28 designer ChRs predicted to be highly functional with different combinations of properties, including those predicted to have the highest photocurrent strength, most red-shifted or blueshifted activation wavelengths and off-kinetics from very fast to very slow ( Supplementary Figs. 2 and 3 ).
We synthesized genes encoding the 28 selected designer ChR variants, expressed them in HEK cells and characterized them for their photocurrent properties with patch-clamp electrophysiology (Figs. 1 and 2). All 28 designer ChRs selected using the updated classification model above the 0.4 threshold both localize and function. For each of the designer ChR variants, the measured photocurrent properties correlated well with the model predictions (R > 0.9 for all models) ( Fig. 1f and Supplementary Table 1 ), demonstrating the power of this data-driven predictive method for engineering designer ChRs. As a negative control, we selected two ChR variant sequences from the recombination library that the model predicted would be nonfunctional (ChR_29_10 and ChR_30_10). These sequences resulted from a single-block swap from two of the most highly functional ChR recombination variants tested. As predicted, these sequences were nonfunctional ( Fig. 2b ), which shows that ChR functionality can be attenuated by incorporating even minimal diversity at certain positions.
Sequence and structural determinants of ChR functional properties. We used L1-regularized linear regression models to identify a limited set of residues and structural contacts that strongly influence ChR photocurrent strength, spectral properties and off-kinetics ( Supplementary Fig. 4a ). We can assess the relative importance of each of these sequence and structural features by weighting their contributions using L2-regularized linear regression (Supplementary Data 4 and Supplementary Fig. 4 ). For each functional property, we identified a set of important residues and contacts and their respective weights. A specific residue or contact at a given position is weighted as likely to lead to, for example, low (negative weight) or high (positive weight) photocurrents. A number of residues and contacts most important for tuning spectral properties are proximal to the retinal-binding pocket, including the blue-shifting contact between A206 and F269 and the blue-shifting contact between F265 and I267, which are conserved in the blueshifted parents C1C2 and CheRiff, while the red-shifting contact between F201 and Y217 originates from the red-shifted CsChrimR parent ( Supplementary Fig. 4 ). The most heavily weighted contact contributing to off-kinetics includes the reside D195 (that is, D156 according to ChR2 numbering) ( Supplementary Fig. 4 ), a residue that is part of the DC-gate 1 . Mutation of either the aspartic acid or cysteine within the DC-gate has been shown to decrease off-kinetic speed 14, 27 . While the cysteine in the DC-gate is conserved in all three ChR parents, the aspartic acid at position 195 is only conserved in CheRiff and C1C2 but not in CsChrimR, which has a cysteine at that position. D195 is also part of a contact with L192 that contributes strongly to photocurrent strength ( Supplementary Fig. 4 ).
A number of contacts proximal to retinal contribute strongly to photocurrent strength. For example, the most heavily weighted contact includes A295 (from CsChrimR), which is adjacent to the conserved lysine residue that covalently links retinal ( Supplementary  Fig. 4 ). This position is a serine in both C1C2 and CheRiff.
Machine-guided search identifies ChRs with a range of useful functional properties. We assessed photocurrent amplitude, wavelength sensitivity and off-kinetics of the designer ChRs and the three parental ChRs (Fig. 2 ). In addition to the 28 regression model-predicted ChRs, we also assessed the two top-performing ChRs from the classification models' predictions (ChR_9_4 and ChR_25_9), for a total of 30 model-predicted highly functional ChRs as well as the two negative control ChRs (ChR_29_10, ChR_30_10). Of the 30 model-predicted ChRs, we found 12 variants with at least two times higher blue-light-activated photocurrents than the top-performing parent (CsChrimR) (Fig. 2b ). Three variants exhibit at least 1.7 times higher green-light-activated photocurrents than CsChrimR. Eight variants have larger red-light-activated photocurrents when compared with the blue-light-activated parents (CheRiff and C1C2), though none outperform CsChrimR. Both ChR variants predicted to be nonfunctional by the models produce <30 pA currents. Designer ChRs' off-kinetics span three orders of magnitude (τ off = 10 ms to >10 s) ( Fig. 2c ). This range is quite remarkable given that all designer ChRs are built from sequence blocks of three parents that have similar off-kinetics (τ off = 30-50 ms). We found that five designer ChRs have faster off-kinetics than the fastest parent, while 16 have more than five times slower off-kinetics. The two fastest variants, ChR_3_10 and ChR_21_10, exhibit τ off = 13 ± 0.9 ms and 12 ± 0.4 ms, respectively (mean ± s.e.m.). Four ChRs have particularly slow off-kinetics with τ off > 1 s, including ChR_15_10, ChR_6_10 and ChR_13_10 (τ off = 4.3 ± 0.1 s, 8.0 ± 0.5 s and 17 ± 7 s, respectively). Two ChRs with very large photocurrents, ChR_25_9 and ChR_11_10, exhibit τ off = 220 ± 10 ms and 330 ± 30 ms, respectively.
Three designer ChRs exhibit interesting spectral properties ( Fig. 2d and Supplementary Fig. 5 ). ChR_28_10's red-shifted spectrum matches that of CsChrimR, demonstrating that incorporating sequence elements from blue-shifted ChRs into CsChrimR can still generate a red-shifted activation spectrum. ChR_11_10 has a broad activation spectrum relative to the parental spectra, with similar steady-state current strength from 400 to 546 nm light and strong currents (700 ± 100 pA) when activated with 567 nm light. ChR_25_9, on the other hand, exhibits a narrow activation spectrum relative to the parental spectra, with a peak at 481 nm light.
We assessed the light sensitivity of select designer ChRs. Compared with CsChrimR, CheRiff and C1C2, the designer ChRs have at least nine times larger currents at the lowest intensity of light tested (10 −1 mW mm −2 ), larger currents at all intensities of light tested and minimal decrease in photocurrent magnitude over the range of intensities tested (10 −1 -10 1 mW mm −2 ), suggesting that photocurrents were saturated at these intensities and would only attenuate at much lower light intensities ( Fig. 2e ). These select designer ChRs are expressed at levels similar to the CsChrimR parent (the highest-expressing parent), indicating that the improved photocurrent strength of these ChRs is not solely due to improved expression ( Supplementary Figs. 6 and 7) .
We compared three of the top designer ChRs (ChR_9_4, ChR_25_9 and ChR_11_10) with ChR2(H134R) (ref. 6, 28 ), an enhanced photocurrent single mutant of ChR2 commonly used for in vivo optogenetics, and CoChR (from Chloromonas oogama) 11 , reported to be one of the highest-conducting ChRs activated by blue light 11 (Supplementary Fig. 8 ). The selected designer ChRs produce three to six times larger photocurrents than ChR2(H134R) when exposed to high-intensity (2.2 mW mm −2 ) 481 nm light and 10-18 times larger photocurrents than ChR2(H134R) when exposed to low-intensity (6.5 × 10 −2 mW mm −2 ) 481 nm light ( Supplementary Fig. 8d-g) . Although CoChR produced peak currents of similar magnitude to the designer ChRs, CoChR decays to a much lower steady-state level ( Supplementary Fig. 8d,e) , with the designer ChRs producing two to three times larger steadystate photocurrents than CoChR when exposed to high-intensity light and three to four times larger steady-state photocurrents than CoChR when exposed to low-intensity light ( Supplementary  Fig. 8f,g and Supplementary Table 4 ). The increased low-light sensitivity of these select designer ChRs is likely due in part to their relatively slow off-kinetics, leading to the increased accumulation of the open state under low-light conditions 14 .
Validation of designer ChRs for neuroscience applications. For further validation we selected three of the top high-conductance ChRs, ChR_9_4, ChR_25_9 and ChR_11_10, and renamed them ChRger1, ChRger2 and ChRger3, respectively, for channelrhodopsin Gaussian process-engineered recombinant opsin ( Fig. 3 and Supplementary Fig. 9 ). When expressed in cultured neurons, the ChRgers display robust membrane localization and expression throughout the neuron soma and neurites (Fig. 3b ). The ChRgers outperform both CoChR and ChR2(H134R) in photocurrent strength with low-intensity light in neuronal cultures (Fig. 3c ). The designer ChRgers require one to two orders of magnitude lower light intensity than CoChR and ChR2(H134R) for neuronal activation ( Fig. 3d and Supplementary Fig. 8h ).
Next, we performed direct intracranial injections into the mouse prefrontal cortex (PFC) of rAAV-PHP.eB packaging either ChRger1-3 or ChR2(H134R) under the hSyn promoter (Supplementary Table 5 ). After 3-5 weeks of expression, we measured light sensitivity in ChR-expressing neurons in acute brain slices. We observed greater light sensitivity for the ChRgers compared with ChR2(H134R) (Fig. 3g,h) . The ChRgers exhibit >200 pA photocurrent at 10 −3 mW mm −2 , while at the equivalent irradiance ChR2(H134R) exhibits undetectable photocurrents. The ChRgers reach >1,000 pA photocurrents with ~10 −2 mW mm −2 light, a fourfold improvement over ChR2(H134R)'s irradiance-matched photocurrents ( Fig. 3g ). Our characterization of ChR2(H134R)'s light sensitivity and photocurrent strength is consistent with previous results from other laboratories 6, 22 .
Designer ChRs and systemic AAVs enable minimally invasive optogenetic excitation. We investigated whether these light-sensitive, high-photocurrent ChRs could provide optogenetic activation coupled with minimally invasive gene delivery. Previous reports of noninvasive optogenetics relied on invasive intracranial virus delivery, which results in many copies of virus per cell and thus very high expression levels of the injected construct 29 . The AAV capsid rAAV-PHP.eB (ref. 19 ) produces broad transduction throughout the central nervous system with a single minimally invasive intravenous injection in the adult mouse 30, 31 . Use of rAAV-PHP.eB for optogenetic applications has been limited, however, by the low multiplicity of infection with systemically delivered viral vectors, resulting in insufficient opsin expression and light-evoked currents to control neuronal firing with commonly used channels (for example, ChR2).
We hypothesized that the ChRgers could overcome this limitation and allow large-volume optogenetic excitation following systemic transgene delivery. We systemically delivered rAAV-PHP. eB packaging ChRger1-3, CoChR or ChR2(H134R) under the hSyn promoter and observed broad expression throughout the brain (Fig. 3i ). Using cell-attached recordings in acute brain slices, we measured the fraction of opsin-expressing cells with sufficient opsin-mediated currents for light-induced firing (Fig. 3j ). Only 4% of ChR2(H134R)-expressing neurons produced light-induced firing, while 77% of CoChR-expressing neurons, 89% of ChRger1expressing neurons and 100% of ChRger2-or ChRger3-expressing neurons produced light-induced activity. With systemic delivery, we observed superior light sensitivity of ChRgers compared with CoChR in both photocurrent strength ( Fig. 3k ) and spike fidelity (Fig. 3l ). ChRger2-expressing neurons exhibit healthy membrane properties similar to CoChR-or ChR2(H134R)-expressing neurons both in culture and in slice ( Supplementary Fig. 10 and Supplementary Table 6 ). These results demonstrate the need for light-sensitive and high-photocurrent opsins for applications where systemic delivery is desired. We systemically delivered rAAV-PHP.eB packaging ChRger1-3 under the CaMKIIa promoter. With systemic delivery of ChRger2, we observed photocurrent strength similar to results observed after direct injection into the PFC in acute brain slices (Fig. 3g ). When expressed in pyramidal neurons in the cortex, ChRger2 and ChRger3 enabled robust optically induced firing at rates between 2 and 10 Hz, although spike fidelity was reduced at higher frequency stimulation (Fig. 3m,n) . ChRger2 performed best with higher frequency stimulation while ChRger1 performed worst. CoChR has better spike fidelity than the ChRgers at higher frequency stimulation (20-40 Hz) (Fig. 3m) .
We next evaluated the optogenetic efficiency of ChRger2 using optogenetic intracranial self-stimulation of dopaminergic neurons of the ventral tegmental area (VTA) 32 . We systemically delivered rAAV-PHP.eB packaging a double-floxed inverted open reading frame (DIO) containing either ChRger2 or ChR2(H134R) into Dat-Cre mice (Fig. 4a,b and Supplementary Table 5 ). At 3 weeks after systemic delivery and stereotaxic implantation of fiber-optic cannulas above the VTA, we placed mice in an operant box and conditioned them to trigger a burst of 447 nm laser stimulation via nose poke. Animals expressing ChRger2 displayed robust optogenetic self-stimulation in a frequency-dependent and laser power-dependent manner. Higher frequencies (up to 20 Hz) and higher light power (up to 10 mW) promoted greater maximum operant response rates (Fig. 4c) . Conversely, laser stimulation failed to reinforce operant responding in ChR2(H134R)-expressing animals (Fig. 4c) ; these results were consistent with results in acute slice where the light-induced currents of ChR2(H134R) are too weak at the low copy number produced by systemic delivery for robust neuronal activation.
To determine whether ChRger2 would enable both minimally invasive transgene delivery and minimally invasive optical excitation, we assayed directional control of locomotion in freely moving animals by optogenetic stimulation of the right secondary motor cortex (M2) 33 . In this assay, unilateral stimulation of M2 disrupts motor function in the contralateral lower extremities, causing mice to turn away from the stimulation side. We systemically administered rAAV-PHP.eB packaging either ChRger2 or ChR2(H134R) under a CaMKIIa promoter for transgene expression in excitatory pyramidal neurons in the cortex ( Fig. 4d and Supplementary Table 5 ). We observed broad expression throughout the cortex for both ChRger2-and ChR2(H134R)-injected animals into wild-type (WT) animals (left) coupled with surgically secured fiber-optic cannula guide to the surface of the skull above the right M2 that had been thinned to create a level surface for the fiber-skull interface (right). e, Expression of ChR2(H134R) (left) and ChRger2 (right) in coronal slices throughout the cortex, including higher-magnification insets of M2. f,g, Turning behavior during unilateral light stimulation of M2 at the indicated wavelengths with ChRger2 and ChR2(H134R). ChRger2, n = 5 animals; ChR2(H134R), n = 5 animals. Plotted data are mean ± s.e.m.
( Fig. 4e and Supplementary Fig. 11 ). We secured a fiber-optic cannula guide to the surface of the thinned skull above M2 without puncturing the dura and therefore leaving the brain intact ( Fig. 4e) , which we consider to be minimally invasive. Despite the presence of the optically scattering calavarial bone, stimulation with 20 mW 447 nm light-induced left-turning behavior in animals expressing ChRger2 but not in animals expressing ChR2(H134R) (Fig. 4f,g and Supplementary Videos 1 and 2) . Left-turning behavior terminated on conclusion of optical stimulation (Supplementary Video 1) . Behavioral effects were seen at powers as low as 10 mW. To ensure that the turning behavior was not due to visual stimuli or heating caused by the stimulation laser, we repeated treadmill experiments using 671 nm light, which is outside the excitation spectrum of both opsins. Furthermore, 20 mW 671 nm light failed to induce turning in both ChRger2 and ChR2(H124R). Overall, these experiments demonstrate that ChRger2 is compatible with systemic gene delivery and can enable minimally invasive optogenetic excitation.
Discussion
We demonstrated a data-driven approach to engineering ChR properties that enables efficient discovery of highly functional ChR variants based on data from relatively few variants. In this approach we approximate the ChR fitness landscape for a set of ~120,000 chimeric ChRs and use it to efficiently search sequence space and select top-performing variants for a given property 10, 24, 34 . By first eliminating the vast majority of nonfunctional sequences, we can focus on local peaks scattered throughout the landscape. Then, using regression models, we predict which sequences lie on the fitness peaks.
Machine learning provides a platform for simultaneous optimization of multiple ChR properties that follow engineering specifications. Application of this machine-learning pipeline (limited data collection from diverse sequences, model training and validation, and prediction and testing of new sequences) has great potential to optimize other neuroscience tools; for example, anion-conducting ChRs 12 , calcium sensors, voltage sensors 35 and AAVs 30 .
We designed high-performance ChRs (ChRger1-3) with unprecedented light sensitivity and validated ChRger2's application for in vivo optogenetics. The high-photocurrent properties of these ChRs overcome the limitation of low per-cell copy number after systemic delivery. Systemically delivered ChRgers have great potential for optogenetic activation of neuronal populations that are difficult to access surgically (for example, DRG, nodose ganglia, sympathetic chain ganglia and cardiac ganglia) or are widely distributed (for example, the enteric nervous system). Coupling ChRgers with recently reported upconversion nanoparticles may allow for noninvasive optogenetics in deep brain areas with systemic transgene delivery and tissue-penetrating near-infrared light for neuronal excitation 29 . ChRger2 enabled neuronal excitation with high temporal precision without invasive intracranial surgery for virus delivery or fiber-optic implantation for superficial brain areas, extending what is currently possible for optogenetics experiments. 
Methods
Construct design and cloning. The design, construction and characterization of the recombination library of chimeras are described in detail by Bedbrook et al. 9 . The ten-block contiguous and ten-block noncontiguous recombination libraries were designed and built using SCHEMA recombination 9 . Software packages for calculating SCHEMA energies are openly available at cheme.che.caltech.edu/ groups/fha/Software.htm. Each chimeric ChR variant in these libraries is composed of blocks of sequence from the parental ChR (CsChrimR (ref. 11 ), C1C2 (ref. 17 ) and CheRiff (ref. 22 )), including chimeras with single-block swaps (chimeras consisting of nine blocks of one parent and a single block from one of the other two parents) and multi-block-swap chimera sequences. Selected ChR variant genes were inserted into a constant vector backbone (pFCK from Addgene plasmid no. 51693 (ref. 22 )) with a Golgi export trafficking signal sequence (KSRITSEGEYIPLDQIDINV) 5 and fluorescent protein (mKate). All ChR variants contain the SpyTag sequence following the N-terminal signal peptide for the SpyTag/SpyCatcher labeling assays used to characterize ChR membrane localization 9, 36 . The C1C2 parent for the recombination libraries is mammalian codon-optimized. ChR variant sequences used in this study are documented in Supplementary Data 2. All selected ChR genes were synthesized and cloned in the pFCK mammalian expression vector by Twist Bioscience. For visualization, sequence alignment between C1C2 and designer ChRs were created using ClustalΩ and visualized using ENDscript 37 ( Supplementary Fig. 3 ).
For characterization in neurons, selected ChR variants (ChRger1, ChRger2, ChRger3, CoChR 11 and hChR2(H134R)) were inserted into a pAAV-hSyn vector backbone (Addgene plasmid no. 26973), a pAAV-CamKIIa vector backbone (Addgene plasmid no. 51087) and a pAAV-CAG-DIO vector backbone (Addgene plasmid no. 104052). In all backbones, each ChR was inserted with a trafficking signal sequence 5 and fluorescent protein (eYFP).
HEK293T cell and primary neuronal cultures. The culturing and characterization of ChRs in HEK cells is described by Bedbrook et al. 9, 36 . Briefly, HEK cells were cultured at 37 °C and 5% CO 2 in D10 (DMEM supplemented with 10% (vol/ vol) fetal bovine serum, 1% sodium bicarbonate and 1% sodium pyruvate). HEK cells were transfected with purified ChR variant DNA using FuGENE 6 reagent according to the manufacturer's (Promega) recommendations. Cells were given 48 h to express the ChRs before photocurrent measurements. Primary hippocampal neuronal cultures were prepped from C57BL/6N mouse embryos 16-18 d postfertilization (Charles River Laboratories) and cultured at 37 °C in the presence of 5% CO 2 in Neurobasal media supplemented with glutamine and B27. Cells were transduced 3-4 d after plating with rAAV-PHP.eB packaging ChR2(H134R), CoChR, ChRger1, ChRger2 or ChRger3. Whole-cell recordings were performed 5-10 d after transduction.
Patch-clamp electrophysiology. Whole-cell patch-clamp and cell-attached recordings were performed in transfected HEK cells, transduced cultured neurons and acute brain slices to measure light-activated inward currents or neuronal firing. For electrophysiological recordings, cultured cells were continuously perfused with extracellular solution at room temperature (in mM: 140 NaCl, 5 KCl, 10 HEPES, 2 MgCl 2 , 2 CaCl 2 , 10 glucose; pH 7.35) while mounted on the microscope stage. For slice recordings, 32 °C artificial cerebrospinal fluid was continuously perfused over slices. Artificial cerebrospinal fluid contained 127 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 12 mM D-glucose, 0.4 mM sodium ascorbate, 2 mM CaCl 2 and 1 mM MgCl 2 and was bubbled continuously with 95% oxygen/5% CO 2 . Firing and photocurrent measurements were performed in the presence of 3 mM kynurenic acid and 100 μM picrotoxin to block optically evoked ionotropic glutamatergic and GABAergic currents, respectively.
Patch pipettes were fabricated from borosilicate capillary glass tubing (1B150-4; World Precision Instruments) using a model P-2000 laser puller (Sutter Instruments) to resistances of 3-6 MΩ. Pipettes were filled with K-gluconate intracellular solution containing the following (in mM): 134 K-gluconate, 5 EGTA, 10 HEPES, 2 MgCl 2 , 0.5 CaCl 2 , 3 ATP and 0.2 GTP. Whole-cell patch-clamp and cell-attached recordings were made using a Multiclamp 700B amplifier (Molecular Devices), a Digidata 1440 digitizer (Molecular Devices) and a PC running pClamp (version 10.4) software (Molecular Devices) to generate current injection waveforms and to record voltage and current traces.
Photocurrents were recorded from cells in voltage clamp held at −60 mV. Neuronal firing was measured in current-clamp mode with current injection for a −60 mV holding potential. Access resistance (R a ) and membrane resistance (R m ) were monitored throughout recording, and cells were discarded if R a or R m changed more than 15%. During ChR variant functional screening in HEK cells, photocurrents were only recorded from cells that passed our recording criteria: R m > 200 MΩ and holding current >−100 pA. Our measured membrane properties of ChR-expressing neurons were consistent with previous literature of opsinexpressing cells 11 and are also consistent with previous reports of properties of cultured hippocampal neurons 38, 39 and PFC neurons in slice 40, 41 ( Supplementary  Fig. 10 ). For cell culture experiments, the experimenter was blinded to the identity of the ChR being patched but not to the fluorescence level of the cells. For acute slice recordings, the experimenter was not blinded to the identity of the ChR.
Light delivery and imaging. Patch-clamp recordings were done with short light pulses to measure photocurrents. Light-pulse duration, wavelength and power were varied depending on the experiment (as described in the text). Light pulses were generated using a Lumencor SPECTRAX light engine. The illumination/ output spectra for each color were measured ( Supplementary Fig. 5 ). To evaluate normalized green photocurrent, we measured photocurrent strength at three wavelengths (peak ± half width at half maximum): (red) 640 ± 3 nm, (green) 546 ± 16 nm and (cyan) 481 ± 3 nm with a 0.5 s light pulse. Light intensity was matched for these measurements, with 481 nm light at 2.3 mW mm −2 , 546 nm light at 2.8 mW mm −2 and 640 nm light at 2.2 mW mm −2 . For full spectra measurements depicted in Fig. 2d , we measured photocurrents at seven different wavelengths (peak ± half width half maximum): (red) 640 ± 3 nm, (yellow) 567 ± 13 nm, (green) 546 ± 16 nm, (teal) 523 ± 6 nm, (cyan) 481 ± 3 nm light-emitting diode (LED), (blue) 439 ± 8 nm LED and (violet) 397 ± 3 nm with a 0.5 s light pulse for each color. Light intensity is matched across wavelengths at 1.3 mW mm −2 .
Imaging of ChR variant expression in HEK cells was performed using an Andor Neo 5.5 sCMOS camera and Micro-Manager Open Source Microscopy Software (v1.4). Imaging of ChR expression in neuronal cultures and in brain slices was performed using a Zeiss LSM 880 confocal microscope and Zen software (v2.3).
Electrophysiology data analysis. Electrophysiology data were analyzed using Clampfit 10.7 (Molecular Devices) and custom data-processing scripts written using open-source packages in the Python programming language to perform baseline adjustments, find the peak and steady-state inward currents, perform monoexponential fits of photocurrent decay for off-kinetic properties and quantify spike fidelity. Only neurons with an uncompensated series resistance between 5 and 25 MΩ, R m > 90 MΩ and holding current >−150 pA (holding at −60 mV) were included in data analysis ( Supplementary Fig. 10 ). The photocurrent amplitude was not adjusted for expression level since both expression and conductance contribute to the in vivo utility of the tool. However, comparisons of expression with photocurrent strength for all ChR variants tested are included in Supplementary Fig. 6 and 7 .
On light exposure, ChRs open and reach a peak inward current and then desensitize reaching a lower steady-state current. As metrics of photocurrent strength, peak and steady-state photocurrent were used (Fig. 1a) . As a metric for the ChR wavelength sensitivity of activation spectrum (that is, spectral properties), the normalized current strength induced by exposure to green light (546 nm) was used ( Fig. 1a) , which easily differentiates blue-shifted ChRs (peak activation: ~450-480 nm) and red-shifted ChRs (peak activation: ~520-650 nm). Two parameters were used to characterize ChR off-kinetics: the time to reach 50% of the light-activated current after a 0.5 s light pulse and the photocurrent decay rate (τ off ) after a 1 ms light exposure (Fig. 1a) .
AAV production and purification. Production of recombinant AAV-PHP.eB packaging pAAV-hSyn-X-TS-eYFP-WPRE, pAAV-CAG-DIO[X-TS-eYFP]-WPRE and pAAV-CaMKIIa-X-TS-eYFP-WPRE (X = ChR2(H134R), CoChR, ChRger1, ChRger2 and ChRger3) was done following the methods described by Deverman et al. 42 and Challis et al. 31 . Briefly, triple transfection of HEK293T cells (ATCC) was performed using polyethylenimine. Viral particles were harvested from the media and cells. Virus was then purified over iodixanol (Optiprep, Sigma; D1556) step gradients (15%, 25%, 40% and 60%). Viruses were concentrated and formulated in PBS. Virus titers were determined by measuring the number of DNase I-resistant viral genomes using quantitative PCR with linearized genome plasmid as a standard.
Animals. All procedures were approved by the California Institute of Technology Institutional Animal Care and Use Committee. Dat-Cre mice (006660) and C57Bl/6J mice (000664) were purchased from the Jackson Laboratory.
Intravenous injections, stereotactic injections and cannula implantation.
Intravenous administration of rAAV vectors was performed by injecting the virus into the retro-orbital sinus at viral titers indicated in the text. There were no observed health issues with animals after systemic injection of virus at the titers presented in the paper. Mice remained healthy >6 months after systemic delivery of ChR2 and ChRgers. With slice electrophysiology, there was no observed indication of poor cell health due to viral-mediated expression, which was quantified by measuring the membrane resistance (R m ), leak current (holding at −60 mV) and resting membrane potential ( Supplementary Fig. 10 ). Local expression in the PFC was achieved by direct stereotactic injection of 1 μl of purified AAV vectors at 5 × 10 12 viral genomes per ml targeting the following coordinates: anteriorposterior (AP), −1.7; media-lateral (ML), ±0.5; and dorsal-ventral (DV), −2.2. For stimulation of the VTA, 300 μm outer diameter mono fiber-optic cannulae (Doric Lenses, MFC_300/330-0.37_6mm_ZF1.25_FLT) were stereotaxically implanted 200 μm above the VTA bilaterally targeted to the following coordinates: AP, −3.44 mm; ML, ±0.48 mm; DV, 4.4 mm. For stimulation of the right M2, 3-mm-long, 400 μm mono fiber-optic cannulae (Doric Lenses, MFC_400/430-0.48_3mm_ZF1.25_FLT) were surgically secured to the surface of the skull above M2 (unilaterally) targeted to the following coordinates: AP, 1 mm; ML, 0.5 mm.
